O
Ona Therapeutics
Specializes in the discovery and development of therapeutic biologics targeting the lipid metabolism in order to treat advanced cancer
About Ona Therapeutics
ONA Therapeutics is a startup operating in the biotechnology sector, specifically focusing on the development of therapeutic solutions for cancer treatment. The company's primary clientele includes healthcare providers and patients seeking advanced cancer treatments. ONA Therapeutics operates in a highly specialized market, where the demand for innovative and effective cancer therapies is consistently high.
Read full description
The business model of ONA Therapeutics revolves around the research, development, and commercialization of novel therapies. The company invests heavily in research and development to create innovative treatments. Once a product is developed and approved for use, the company generates revenue through its sale to healthcare providers.
In terms of data protection, ONA Therapeutics adheres to the Regulation (EU) 2016/679 of the European Parliament and of the Council, ensuring the confidentiality, integrity, and security of personal data provided through its web portal. The company uses this data to respond to queries about its services and, with user consent, to send electronic information. The company does not share this data unless required by law or for services related to its information systems.
In addition, ONA Therapeutics uses cookies on its website to provide the requested service by the user. The company does not use these cookies for automated individual decisions or profiling, ensuring user privacy.
At a glance
- Status
- Operational
- Founded
- 2019
- Headquarters
- Barcelona, Spain
- Employees
- 35
- Open positions
- 2
- Dealroom signal
- 71.3/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Oncology, Spinout, Biotech and Pharma, Hard Tech, Woman Founder, participations bpifrance, radar de l'innovation, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning Ona Therapeutics.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Jun 2026 | $87M | $346M | Bpifrance · Cofides · CDTI · Asabys Partners | ↗ |
| EARLY VCOther financing | Oct 2025 | $11M | $165M | Alta Life Sciences · CDTI Innvierte · Ysios Capital · FundPlus | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Ona Therapeutics is 5.6K monthly website visits, up 3900% over the last three months. Ona Therapeutics's team grew 0% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Asabys Partners
Series A10 investors entered at this stage
Ysios Capital
Alta Life Sciences
FundPlus
Bpifrance
CDTI Innvierte
Mérieux Equity Partners
Columbus Venture Partners
Cofides
CDTI
Korys
Other known investors3 additional known investors
Barcelona Institute of Science and Technology
ICREA
IRB Barcelona - Institute for Research in Biomedicine
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Ona Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ona Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.